| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CELL.2005.10.017 |
| P698 | PubMed publication ID | 16269324 |
| P50 | author | Nancy M. Bonini | Q47503546 |
| P2093 | author name string | Benoit I Giasson | |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Synuclein | Q24767155 |
| P304 | page(s) | 359-361 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Snaring the function of alpha-synuclein | |
| P478 | volume | 123 |
| Q37960537 | 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies |
| Q38212199 | Aberrant autophagy and parkinsonism: does correction rescue from disease progression? |
| Q35048929 | Acceleration of α-synuclein aggregation by exosomes |
| Q28079911 | Alpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical Application |
| Q39670506 | Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells |
| Q27003541 | Alpha-synuclein biology in Lewy body diseases |
| Q89529472 | Alternative Structures of α-Synuclein |
| Q34379982 | Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay |
| Q39348525 | Arachidonic acid mediates the formation of abundant alpha-helical multimers of alpha-synuclein |
| Q24323344 | Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synuclein |
| Q35094391 | Bridging molecular genetics and biomarkers in lewy body and related disorders |
| Q43256880 | Characterization of intrinsically disordered proteins with electrospray ionization mass spectrometry: conformational heterogeneity of alpha-synuclein |
| Q24293110 | Coordination features and affinity of the Cu²+ site in the α-synuclein protein of Parkinson's disease |
| Q36530499 | Coordination of copper to the membrane-bound form of α-synuclein |
| Q23914777 | Correlation between the biochemical pathways altered by mutated Parkinson-related genes and chronic exposure to manganese |
| Q38972171 | DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease |
| Q28573979 | Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression |
| Q34277399 | Direct observation of the interconversion of normal and toxic forms of α-synuclein |
| Q40084749 | Discovery and characterization of three novel synuclein genes in zebrafish |
| Q48163417 | Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells |
| Q37995991 | Hunting the chameleon: structural conformations of the intrinsically disordered protein alpha-synuclein. |
| Q37302816 | Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases |
| Q38296498 | Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein |
| Q30577687 | Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease |
| Q36569512 | Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores |
| Q58710388 | Investigation of α-Synuclein Amyloid Fibrils Using the Fluorescent Probe Thioflavin T |
| Q36659034 | Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading |
| Q64074236 | Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications |
| Q47101012 | MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation |
| Q38401326 | Mini review: linkage between α-Synuclein protein and cognition |
| Q37350413 | Molecular and cellular biology of synucleins |
| Q40778644 | Mutant alpha-synuclein overexpression mediates early proinflammatory activity |
| Q34538864 | Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation |
| Q34648491 | Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation |
| Q30354689 | Noradrenergic Modulation of Cognition in Health and Disease. |
| Q38299726 | PCR-verified microarray analysis and functional in vitro studies indicate a role of alpha-tocopherol in vesicular transport |
| Q90215258 | Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases |
| Q48246699 | Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease |
| Q52718516 | Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods. |
| Q42452052 | Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease. |
| Q90103351 | Propofol Attenuates α-Synuclein Aggregation and Neuronal Damage in a Mouse Model of Ischemic Stroke |
| Q38468247 | Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease |
| Q30376386 | Protein Misfolding in Lipid-Mimetic Environments. |
| Q38038126 | Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease |
| Q30446460 | Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. |
| Q26740342 | Role of ROS and RNS Sources in Physiological and Pathological Conditions |
| Q48599325 | Role of α-synuclein in neurodegeneration: implications for the pathogenesis of Parkinson's disease. |
| Q41963683 | Saliva α-Synuclein and A High Extinction Coefficient Protein: A Novel Approach in Assessment Biomarkers of Parkinson's Disease. |
| Q33571628 | Sleep disorders in neurodegenerative diseases |
| Q41000436 | Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic? |
| Q35416913 | Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. |
| Q38039857 | Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration |
| Q34562198 | Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of pre-existing oligomers in alpha-synuclein fibrillization |
| Q24316619 | The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes |
| Q41525066 | The impact of genetic research on our understanding of Parkinson's disease |
| Q38613361 | The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation |
| Q37070916 | alpha-Synuclein: a therapeutic target for Parkinson's disease? |
| Q42111186 | α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2. |
| Q41670950 | α-synuclein induced synapse damage is enhanced by amyloid-β1-42. |
Search more.